Psychiatric drugs fare favorably when companies pay for studies
Posted 5/24/2006 11:37 PM ET
Posted 5/24/2006 11:37 PM ET
By Marilyn Elias, USA TODAY
Drug companies fund a growing number of the studies in leading psychiatric journals, and drugs fare much better in these company-funded studies than in trials done independently or by competitors, researchers reported Wednesday.
About 57% of published studies were paid for by drug companies in 2002, compared with 25% in 1992, says psychiatrist Igor Galynker of Beth Israel Medical Center in New York City.
No comments:
Post a Comment